With the 2023 revision to USP Chapter 797, compliance requirements for compounding pharmacies have grown more demanding: stricter documentation, environmental monitoring, competency checks, and robust batch / beyond-use date (BUD) tracking. Many pharmacies especially those preparing high-risk sterile or nonsterile-to-sterile compounded preparations face operational and compliance challenges under the new norms.

To address this, Wolters Kluwer has unveiled its Advanced Compounding module as part of its Simplifi 797 suite. The module offers a closed-loop digital solution for pharmacies: from batch record creation and tracking, BUD management, environmental condition logging (cleanroom monitoring), to audit-ready documentation and reporting. 

Beyond workflow automation, the module also includes comprehensive educational resources  SOPs, training materials, competency assessments, and environmental-monitoring data capture  enabling staff competency documentation and compliance under USP guidelines. This helps reduce reliance on manual logs and mitigates risk of human errors. 

Pharmacies using the version of Simplifi 797 with this module will now be able to manage the full scope of compounding from immediate-use to Category 3 / high-risk compounding  under a unified, digitally managed, audit-ready compliance framework.